white logo

Serum Institute of India

Preliminary approval for the making of Covishield given to SII: Final decision of DCGI pending

New Delhi, January 1, 2021 The SII or the Serum Institute of India, that is making Covishield, the vaccine that has been developed by the Oxford University and AstraZeneca the…

Read More